Drug Stocks Are the New Safe Bet in a Shaky Market
After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.
After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) announced better-than-expected revenue in Q4 CY2024, with sales up 44.8% year on year to $190.6 million. The company’s full-year revenue guidance of $766 million at the midpoint came in 5.7% above analysts’ estimates. Its non-GAAP profit of $1.63 per share was 13.6% above analysts’ consensus estimates.
Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 18.4% year on year to $730.5 million. The company’s full-year revenue guidance of $3.05 billion at the midpoint came in 4.5% above analysts’ estimates. Its non-GAAP profit of $0.12 per share was 21.1% below analysts’ consensus estimates.
(Reuters) -Wall Street ended higher on Friday after a choppy trading session, with Dell Technologies dipping and other tech stocks climbing after a meeting between the U.S. President Donald Trump and Ukrainian counterpart Volodymyr Zelenskiy ended in disaster. Zelenskiy and Trump traded verbal blows at the White House before the world's media. This created fresh uncertainty over Ukraine's war with Russia for investors already worried about sticky U.S. inflation and a tepid economy.
Whether Adidas can win more American shoppers from market leader Nike will be key to its continued success this year, investors and analysts said, as the German brand looks for new sources of growth beyond its Samba and Gazelle sneakers. Uncertainty over whether consumer demand in China will recover has driven many brands, including in the luxury sector, to focus more on U.S. shoppers as a growth driver for 2025. Chief Executive Bjorn Gulden has turned Adidas around since the brand cut ties with rapper Ye and scrapped its lucrative Yeezy sneaker line in October 2022.
(Bloomberg) -- Dip buyers are missing in action as the narrative for stocks is quickly souring due to the negative news flow on trade.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyThe Trump Administration Takes Aim at Transportation ResearchShelters Await Billions in Federal Money for Homelessness ProvidersNYC Office Buildings See Resurgence as Investors Pile Into BondsNYC’s Congestion Pricing Pulls In $48.6 Million in First MonthIt’s a “manic headline rou
Money market account rates vary widely. So which banks are offering the best money market account rates today? Find out here.
(Bloomberg) -- Emerging markets were swept up in the global equities storm Friday, with Asian stocks taking the heaviest beating after President Donald Trump’s latest tariff threats.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyThe Trump Administration Takes Aim at Transportation ResearchShelters Await Billions in Federal Money for Homelessness ProvidersNYC Office Buildings See Resurgence as Investors Pile Into BondsNYC’s Congestion Pricing Pulls In $48.6
Deborah Elms, head of trade policy for the Hinrich Foundation, said: “I do not know anyone who anticipated another 10% tariff against China so soon."
(Bloomberg) -- Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyThe Trump Administration Takes Aim at Transportation ResearchShelters Await Billions in Federal Money for Homelessness ProvidersNYC Office Buildings See Resurgence as Investors Pile Into BondsNYC’s Congestion Pricing Pulls In $48.6 Million in First MonthIndia’